EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudieOpen Access · CC BY-NC 4.0

Initial 12 mg Versus 6 mg Adenosine for Supraventricular Tachycardia in the Emergency Department

Ekrem Taha Sert iD, Kamil Kokulu, Oğuz Yürük, Emin Hüseyin Akar, Muhammed Ali Topuz

Academic Emergency Medicine · 2026-05 · 33 (5)

DOI: 10.1111/acem.70309 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Academic Emergency Medicine, online erschienen am 29.04.2026. Verfasst von Ekrem Taha Sert und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Aksaray University Faculty of Medicine, Aksaray, Turkey. Hauptthemen laut MEDLINE: Tachycardia, Supraventricular, Adenosine, Anti-Arrhythmia Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to compare the efficacy and safety of an initial 12 mg versus 6 mg adenosine dose for sinus rhythm conversion in patients presenting with supraventricular tachycardia (SVT) in the emergency department (ED).

Methods

This prospective observational study was conducted between February 2025 and January 2026. Adult patients (≥ 18 years) presenting to the ED with hemodynamically stable SVT confirmed by 12‐lead electrocardiography (ECG) were included. Patients were categorized into two groups according to the initial adenosine dose administered (6 mg vs. 12 mg). To address potential selection bias, 1:1 propensity score matching (PSM) was performed. The primary outcome was successful first‐dose sinus rhythm conversion. Secondary outcomes included adenosine‐related adverse effects and SVT recurrence during the ED stay.

Results

A total of 142 patients were analyzed ( n = 71 per group). First‐dose conversion was significantly higher with 12 mg compared with 6 mg (83.1% vs. 52.1%). In the PSM cohort ( n = 104), the 12 mg dose maintained its superior efficacy (82.7% vs. 53.8%). The PSM‐adjusted odds ratio for successful conversion was 4.12 (95% confidence interval [CI]: 1.85–9.14), with a number needed to treat (NNT) of 3.8 (95% CI: 2.5–8.3). SVT recurrence was numerically lower in the 12 mg group (1.4% vs. 9.9%). Adverse effects were similar between groups.

Conclusions

An initial 12 mg adenosine dose was associated with higher first‐dose sinus rhythm conversion than 6 mg, while adverse effects were similar between groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tachycardia, SupraventricularAdenosineAnti-Arrhythmia AgentsHumansFemaleEmergency Service, HospitalMaleProspective StudiesMiddle AgedElectrocardiographyPropensity ScoreAgedDose-Response Relationship, DrugTreatment OutcomeAdult

Stichwörter der Autor:innen

adenosineadverse effectsemergency departmentsinus rhythm conversionsupraventricular tachycardia

Substanzen

AdenosineAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Emergency Medicine, Aksaray University Faculty of Medicine, Aksaray, Turkey.

ORCID-Profile: Ekrem Taha Sert

Zitieren

APA

Sert, E. T., Kokulu, K., Yürük, O., Akar, E. H., & Topuz, M. A. (2026). Initial 12 mg Versus 6 mg Adenosine for Supraventricular Tachycardia in the Emergency Department. Academic Emergency Medicine, 33(5). https://doi.org/10.1111/acem.70309

Vancouver

Sert ET, Kokulu K, Yürük O, Akar EH, Topuz MA. Initial 12 mg Versus 6 mg Adenosine for Supraventricular Tachycardia in the Emergency Department. Academic Emergency Medicine. 2026;33(5). doi:10.1111/acem.70309

BibTeX
@article{Sert2026,
  author = {Sert, Ekrem Taha and Kokulu, Kamil and Yürük, Oğuz and Akar, Emin Hüseyin and Topuz, Muhammed Ali},
  title = {Initial 12 mg Versus 6 mg Adenosine for Supraventricular Tachycardia in the Emergency Department},
  journal = {Academic Emergency Medicine},
  year = {2026},
  volume = {33},
  number = {5},
  doi = {10.1111/acem.70309}
}
Kostenlos starten →